ATLASProcessa Pharmaceuticals (PCSA) earnings date: Nov 5, 2026
Processa Pharmaceuticals (PCSA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PCSA
| Last price | $1.85 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Processa Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Processa Pharmaceuticals reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Processa Pharmaceuticals. You can switch it off at any time.
Alert me before PCSA reportsFree to start. Creating an account takes under a minute.
PCSA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jul 28, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +3.2% |
| Average move around a report | ±8.9% (last 5) |
| Sector | Healthcare · Biotechnology |
Processa Pharmaceuticals earnings history: last 5 reports
Processa Pharmaceuticals last reported on Jul 28, 2026: EPS of $0.89 against an estimate of $0.87 (+2.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | -21.6% |
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | -1.7% |
| Feb 12, 2026 | $1.03 | $1.07 | +3.9% | Beat | -9.4% |
| Nov 6, 2025 | -$2.00 | -$1.75 | +12.5% | Beat | -10.0% |
| Aug 7, 2025 | -$5.75 | -$6.25 | -8.7% | Miss | +1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PCSA
See the fair value, the probability range and the earnings history of Processa Pharmaceuticals on its ATLAS page.
Processa Pharmaceuticals (PCSA) stock analysisPlans from €3.99 a month.
Processa Pharmaceuticals earnings: frequently asked questions
When does Processa Pharmaceuticals (PCSA) report earnings?
Processa Pharmaceuticals is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does PCSA beat earnings estimates?
Of its last 5 reports with a recorded result, Processa Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +3.2%. Past results do not predict the next one.
How much does PCSA move around earnings?
Over its last 5 reports the stock moved an average of 8.9% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Processa Pharmaceuticals beat earnings estimates last quarter?
Processa Pharmaceuticals last reported on Jul 28, 2026: EPS of $0.89 against an estimate of $0.87 (+2.3% surprise), a beat.
How much does PCSA usually move in a day?
On a normal trading day the ATLAS model puts PCSA’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer